| 000 | 01702 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250516200620.0 | ||
| 264 | 0 | _c20141112 | |
| 008 | 201411s 0 0 eng d | ||
| 022 | _a2476-762X | ||
| 024 | 7 |
_a10.7314/apjcp.2014.15.2.647 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWang, Nan | |
| 245 | 0 | 0 |
_aApplication of lobaplatin in trans-catheter arterial chemoembolization for primary hepatic carcinoma. _h[electronic resource] |
| 260 |
_bAsian Pacific journal of cancer prevention : APJCP _c2014 |
||
| 300 |
_a647-50 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aCarcinoma, Hepatocellular _xdrug therapy |
| 650 | 0 | 4 | _aCase-Control Studies |
| 650 | 0 | 4 |
_aChemoembolization, Therapeutic _xmethods |
| 650 | 0 | 4 |
_aCyclobutanes _xadministration & dosage |
| 650 | 0 | 4 |
_aDoxorubicin _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHepatic Artery |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfusions, Intra-Arterial |
| 650 | 0 | 4 |
_aLiver Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 |
_aOrganoplatinum Compounds _xadministration & dosage |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aSurvival Rate |
| 700 | 1 | _aLv, Yin-Zhang | |
| 700 | 1 | _aXu, An-Hui | |
| 700 | 1 | _aHuang, Yan-Rong | |
| 700 | 1 | _aPeng, Ling | |
| 700 | 1 | _aLi, Jia-Rui | |
| 773 | 0 |
_tAsian Pacific journal of cancer prevention : APJCP _gvol. 15 _gno. 2 _gp. 647-50 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.7314/apjcp.2014.15.2.647 _zAvailable from publisher's website |
| 999 |
_c23584819 _d23584819 |
||